Gene-encoded antimicrobial peptides (AMPs) are an essential component of the innate immune system in many species. Analysis of β-defensin gene expression in mouse tissue using primers that were specific for conserved sequences located outside of the β- 
Introduction
Innate immunity in animals depends in large part on the activity of nonspecific effector molecules. In particular, gene-encoded antimicrobial peptides (AMPs) are now clearly established as key players in both plant and animal defense systems. Despite broad divergence in sequence and taxonomy, most AMPs share a common mechanism of action involving membrane permeabilization of the pathogen cell membrane.
Importantly, AMPs are recognized as a potential source of therapeutic drugs for the treatment of antibiotic-resistant bacterial infections.
To date, more than 880 different AMPs have been identified or predicted based on nucleic acid sequences. These include AMPs that are produced in many tissues and cell types in a variety of invertebrate, plant and animal species, as well as certain cytokines and chemokines. AMPs are a unique and diverse group of molecules that can be divided into subgroups based on amino acid composition and structure [1, 2] . The subgroup of anionic AMPs includes small peptides present in surfactant extracts, bronchoalveolar lavage fluid and airway epithelial cells. A second subgroup is comprised of approximately 290 linear cationic α-helical peptides. These peptides are short, lack cysteine residues and may possess a hinge or kink in the middle of the peptide. In aqueous solution, many of these peptides are disordered, but in the presence of trifluoroethanol (TFE) or sodium dodecyl sulphate (SDS) micelles, all or part of the molecules are converted to an α-helical conformation [1, 2] .
Using a set of primers designed to amplify conserved mouse β-defensin sequences located outside of the translated region, we identified a novel small gene with an open reading frame of 114 basepairs (bp) and a predicted amino acid sequence of 37 residues.
For some of the members of this subgroup, α-helicity correlates with antimicrobial activity. A third subgroup contains approximately 44 cationic peptides that are rich in certain amino acids. This group includes the bactenecins and PR-39, which are rich in proline and arginine residues. Peptides in this group lack cysteine residues and are linear, although some can form extended coils. A forth subgroup of approximately 380 members consists of anionic and cationic peptides that contain cysteine residues and form disulfide bonds and stable β-sheets. This subgroup includes the diverse family of defensins and protegrin. There are approximately 55 α-defensins, 90 β-defensins, 54 arthropod (insect) defensins, and 58 plant defensins; a rhesus θ-defensin has also been identified.
A search of the genome database (http://www.ensembl.org) revealed that the gene locus and exon 1 sequence of this novel gene were similar to subgroup 1 mouse β-defensins.
We designated this gene mouse β-defensin-like small (mBDLs).
The β-defensin genes consist of two exons. Exon 1 encodes a signal sequence and exon 2 encodes the pro and mature peptides that function as AMPs. The gene structure of mBDLs was similar to other β-defensins, which suggested that the mature peptide was encoded by exon 2. We synthesized a small peptide, K17, based on the nucleotide sequence of exon 2. K17 lacked cysteine residues. The peptide showed random coil conformation in aqueous solution, but formed α-helical structure in the presence of 50% TFE and 1% SDS, a membrane-mimicking environment, as identified by circular dichroism (CD) spectroscopy. The antimicrobial activity of K17 was assessed to determine if it functioned as an α-helical AMP. K17 exhibited bactericidal activity against Gram negative Salmonella enterica serovar Typhimurium and Gram positive Staphylococcus aureus at a concentration that is typical for other defensins. K17 did not exhibit cytotoxicity against normal or transformed mammalian cells (NIH3T3, HeLa, and A549 cells) or hemolytic activity against mouse erythrocytes at concentrations that inhibited bacterial growth. These results suggested that K17 may be a candidate therapeutic for the treatment of bacterial infections.
Materials and Methods

Tissue samples
Murine tissues were obtained from adult C57BL/6 mice. All animal experiments were approved by the Animal Care and Use Committee of the National Institute of Infectious Diseases.
Reverse transcriptase (RT)-PCR
Total RNA was isolated from mouse brain tissue using Trizol (Invitrogen, Carlsbad, 
5'-Rapid amplification of cDNA ends (RACE) and sequencing
To isolate the full-length cDNA for mBDLs, we performed 5'-RACE using the 5'-Full RACE core kit (Takara, Tokyo, Japan) and the following primers: S1, 5'-TAGCCCTCAAATGCTGCAAG-3'; A1, 5'-AAGCTGCAAATGGAGACAGC-3; S2, 5'-AGACAAAGATCCTGTGAACC-3'; and A2, 5'-GCAACACCAGGAGAAATGAG-3'. PCR products were separated on a 2.0% agarose gel and the band of the expected size was removed, purified with a Qiaquick Gel Extraction Kit (Qiagen) and then subcloned into pGEM-T easy (Promega, Madison, WI). The cloned DNA sequence was confirmed by cycle sequencing using the Big Dye Terminator v1.1/3.1Cycle Sequencing Kit (Applied Biosystems, Foster City, CA) and a 3100-Avant Genetic Analyzer (Applied Biosystems).
Genome, sequence, phylogenetic and secondary structure analyses
Genome analysis of the cloned cDNA and its locus was carried out using BLAST searches of the Ensembl genome database (http://www.ensembl.org ). DNASIS pro software (Hitachi Software Engineering, Tokyo, Japan) was used to predict amino acid sequences and perform sequence comparisons. Genetyx software (Genetyx Corporation, Tokyo, Japan) was used to construct the phylogenetic tree of mBDLs and five members of subgroup 1 mouse β-defensins. The PEP-FOLD Server (http://bioserv.rpbs.univparis-diderot.fr/PEP-FOLD) and Antimicrobial Peptide Database (APD; http://aps.unmc.edu/AP/main.html) were used to predict three dimensional (3D) conformations and predict antimicrobial function, respectively.
Peptide synthesis
Based on the predicted amino acid sequence of mBDLs, the small peptide K17
(FSPQMLQDIIEKKTKIL) and the K17 analogue A17, which contained three lysine-toalanine substitutions (FSPQMLQDIIEAA TAIL) were chemically synthesized by Sigma Genosys (Ishikari, Japan).
Bactericidal assay
Bactericidal assays were performed using wild-type and defensin-sensitive phoP strains of Salmonella enterica serovar Typhimurium (S. typhimurium) and Staphylococcus aureus (S. aureus), as described previously [4] . Bacteria were stored at -80 °C in cryopresevant. All assays were performed in duplicate. Bacteria were cultured in Tryptic Soy Broth (TSB). One thousand colony forming units (CFU), as determined by the OD of exponentially growing cultures, were collected by centrifugation and then resuspended in 25 µl of distilled water. Various concentrations of peptide were added to the cells, and the suspension was allowed to incubate for 60 min at 37 °C, at which point CFU were quantified by growth on Tryptic Soy Agar (TSA) plates at 37 °C overnight. The number of CFU of treated samples was compared to controls without peptide.
Growth inhibitory activity against tumor and normal fibroblast cells
Cells were grown in DMEM supplemented with 10% heat-inactivated fetal bovine serum (FBS), 100 units/ml penicillin G and 100 µg/ml streptomycin. Cells were plated on 96-well plates at a concentration of 6 x 10incubating the plates overnight at 37 °C in an atmosphere of 5% CO 2 , the medium was changed to OPTI-Pro without FBS. Ten µl of diluted peptide were added to the cells, and then the plates were incubated for 24 hours (hr), at which point 50 µl of XTT solution from the Cell proliferation kit II [XTT] (Roche Diagnostics, Indianapolis, IN) were added to each well. The plates were incubated for an additional 3 hr, and then absorbance was measured at 490 nm using a microplate ELISA reader (Bio-Rad Laboratories, Hercules, CA).
Hemolysis assay
Hemolytic activity was evaluated by measuring hemoglobin release from fresh mouse erythrocytes. Mouse red blood cells were isolated using a cellulose column.
Erythrocytes were suspended in phosphate buffered saline (PBS; 100 µl) (8% v/v) and then plated on 96-well U-bottomed plates (Nunc, Roskilde, Denmark). Ten µl of peptide dissolved in PBS were added to each well, and then the plates were incubated for 1 hr at 37 °C, after which they were subjected to centrifugation at 1,500 x g for 5 min. The supernatant (100 µl) was then transferred to a 96-well microtiter plate. 
CD spectroscopy
The far-UV CD spectra of K17 and A17 were recorded in a J-805 spectropolarimeter (Jasco, Tokyo, Japan) at room temperature using 0.2 cm path length quartz cuvette.
Both peptides were dissolved in either distilled water, 1% SDS, or 50% TFE at final concentrations of 50 and 100 μg/ml for K17 and A17, respectively.
Statistics
Experimental groups were compared statistically using the Student's t-test. A P value of <0.05 was considered statistically significant.
Results
Identification of the mBDLs gene
RT-PCR analysis of a mouse brain cDNA library was carried out using primers that were specific for conserved mouse β-defensin sequences located outside of the translated region. Amplified products were separated by agarose gel electrophoresis and a small band of approximately 150 bp, which was similar to the expected size of mouse β-defensin genes, was detected (data not shown). To characterize this small PCR product, the amplified fragment was subcloned and sequenced. Analysis by 5'-RACE using a primer designed to target the coding region revealed that the small cDNA contained a 114 bp open reading frame encoding a putative peptide of 37 amino acid residues (Fig. 1A) .
In silico genome scan
The small cDNA sequence was verified using the Emsembl BLASTview program [5] .
There was a 100% match between the isolated small cDNA and a locus on mouse chromosome 8 (database location: AC121131.14, 100856 to 100918). The gene contained 2 exons separated by 1 intron and was 1698 bp in length (Fig. 1B) . In exon 1, the 5'-untranslated region contained an NF-κB binding site and TATA box (Fig. 1B) .
The gene structure was consistent with characteristics commonly found in mouse defensin genes, namely, 2 exons separated by an intron (~1.7 kb) and an NF-κB binding site and TATA box in the 5'-untranslated region [6] .
The A3 region on chromosome 8 is divided into two contigs that are separated by approximately 850 kb. The first contig contains six mouse β-defensin (mBD) genes, including mBD4, 6, 5, 3 and 7, as well as DefR1. These genes all belong to β-defensin subgroup 1. The small gene was located after mBD7 in the first contig (Fig. 1C) . Since the small gene had similar structural characteristics to other mouse β-defensins, it was designated mBDLs, for mouse β-defensin-like small gene.
Prediction of mBDLs amino acid sequence
The amino acid sequence of mBDLs was predicted and compared with other members of the mouse β-defensin family (Fig. 2A) . The cDNA sequence of mBDLs exhibited 60-80% similarity to other subgroup 1 members such as mBD3, mBD4, mBD5, mBD7 and DefR1, but lower homology to subgroup 2 members, including mBD2 and mBD10. The prepro region (amino acids 1-23) of the mBDLs peptide was highly similar to subgroup 1 family members, but the level of similarity was lower for the mature peptide sequence (amino acids 24-66; Fig. 2A ). It has been reported that β-defensin subgroup 1 members contain similar signal sequences and are of similar exon length [7] . As both the sequence and length of mBDLs exon 1 were similar to other subgroup 1 members, we propose that it belongs to the same family. Phylogenetic analysis of mBDLs and five mouse subgroup 1 β-defensin genes showed that mBDLs forms a branch with mBD7, while mBD4 and mBD5 with mBD3 formed other branches (Fig. 2B) . Although mBDLs exhibited similarity to other β-defensin subgroup 1 family members with respect to gene locus and exon-intron structure, as well as by phylogenetic analysis, mBDLs was much smaller than these other defensins and did not contain cysteine residues.
Design of peptides and CD analysis of these peptides
The mature defensin peptide is encoded by exon 2 [8] . Based on the predicted amino acid sequence of mBDLs exon 2, we synthesized a small peptide, termed K17 (FSPQMLQDIIEKKTKIL), and the K17 analogue A17 (FSPQMLQDIIEAATAIL), which contained three alanines in place of the three lysine residues (Fig. 3A) . Structural analysis using PEP-FOLD, which builds on a new de novo approach to predicting 3D peptide structures from sequence information [3] , indicated that K17 and A17 each adopt an α-helical conformation (Figs. 3B and C) . The secondary structures of these peptides were analyzed by a CD spectroscopy. The CD spectra of K17 and A17 dissolved in distilled water exhibited disordered as random coil (Figs. 3D and E) . Upon the addition of 50% TFE or 1% SDS, a conformational change occurred, as evidenced by spectrum containing minima at 208 and 222 nm. Based on these spectra, these peptides adopted α-helical structure in the membrane-mimicking environment. The result is in good agreement with the results of other online prediction , Antimicrobial Peptide Database (APD) that predicts whether these peptides would have antimicrobial activity [10] . According to the APD, K17, which was cationic and could putatively interact with membranes, was predicted to function as an AMP, while A17, which had a net negative charge, would not.
Antimicrobial activity
The bactericidal activity of the two peptides was first examined using the defensinsensitive phoP strain of S. typhimurium. The lack of a PhoP system for antimicrobial resistance makes this strain a useful tool for determining the antimicrobial mechanisms of defensins [4] . At concentrations (5 and 10 μg/ml) that are generally considered optimal for the bactericidal activity of other AMPs, K17 exhibited dose-dependent bactericidal activity against the phoP-strain of S. typhimurium, whereas there was no increase in activity in the presence of A17 (5 and 10 µg/ml) (Fig. 4A) . We next examined bactericidal activity against wild-type S. typhimurium (Gram negative) and S. aureus (Gram positive). K17 showed significantly higher bactericidal activity against S. typhimurium and S. aureus (approximately 40%) as compared to A17 (Fig. 4B) .
Cytotoxicity against mammalian tumor and normal cells
The cytotoxicity of K17 and A17 in mammalian cell cultures was investigated by growth inhibition of normal mouse NIH3T3 fibroblasts and two transformed tumor cell lines (HeLa and A549). Neither K17 nor A17 was cytotoxic in cultures of normal and tumor cells at concentrations of 2, 20, and 200 µg/ml (Fig. 4C) .
Hemolytic activity
The hemolytic activity of K17 and A17 was determined using mouse erythrocytes. No significant hemolytic activity of the peptides was observed at concentrations of 2, 20, and 200 µg/ml (Fig. 4D) .
Discussion
A mouse β-defensin-like gene was amplified from mouse brain using primers designed to target conserved mouse β-defensin gene sequences. This novel gene was designated mouse β-defensin-like small, or mBDLs. The genomic structure of mBDLs was similar to other subgroup 1 β-defensins in that it contained 2 exons separated by 1 intron, was approximately 2 kb [6, 11, 12] , and contained an NF-κB binding site [6, 13, 14] and TATA box [11] in the 5'-untranslated region.
The β-defensin genes possess two exons and one intron. A signal sequence is encoded by exon 1 and the mature peptide is encoded by exon 2 [8] . Because the sequence of exon 1 of mBDLs was similar to other subgroup 1 members, we predicted that exon 2 would encode the mature peptide. We synthesized a small peptide, termed K17, derived from the nucleotide sequence of exon 2 of mBDLs. We also synthesized a K17 analogue that contained alanine residues in place of lysine residues, termed A17. Replacement or deletion of specific amino acid residues in the original peptide is a common technique for analyzing new AMPs [15] , such as cecroprins and maganines [16, 17] . K17 was cationic, lacked cysteine residues, and it was shown that the peptide exhibited α-helical conformation in lipid membrane-mimicking solvents such as 50% TFE or 1% SDS by CD spectroscopy. A17 was also adopted α-helical structure but had negative charge.
AMPs are divided into four subgroups based on amino acid composition and structure.
One of AMPs subgroups is typically α-helical, short, cationic peptides that lack cysteine residues [1] . The characteristics of K17 were consistent with those of the AMP subgroup. Furthermore, the APD predicted that K17 would function as an AMP [10] .
Examination of the antimicrobial activity of K17 and A17 against the phoP-strain of S. typhimurium, which is sensitive to AMPs [4] , and two wild-type strains (S. typhimurium and S. aureus) showed that K17 had antimicrobial activity against Gram positive and Gram negative bacteria at concentrations that are generally considered optimal for the bactericidal activity of other AMPs. The K17 analogue A17, which also adopted an α-helical conformation but lost charge due to replacement of lysines by alanines, lacked antimicrobial activity. While the precise mechanism of action of AMPs is not fully understood [18] , these results suggested that charge is related to antimicrobial activity, at least for K17. Although some α-helical antimicrobial peptides exert cytotoxic and hemolytic effects [19] , K17 was not hemolytic in cultures of mouse erythrocytes or corresponds to main chain lysine residues (arrow heads). Estimated structure of A17, in which Lys-12, 13, and 15 of K17 were replaced with alanine. Gray color in A17 corresponds to main chain alanine residues. Representations were generated using Accelrys Discovery Studio software. under different conditions. The far-UV CD spectra of K17 (50 μg/ml) and A17 (100 μg/ml) was recorded in distilled water (solid line), 1% SDS (dotted line), or 50% TFE (dashed line). 
